Summary:
- This article is an interview with Alessandro Riva, the CEO of Transgene, a French biopharmaceutical company.
- Transgene is focused on developing innovative therapies for infectious diseases and cancer, using their expertise in viral vector-based technologies.
- The interview discusses Transgene's work on developing a COVID-19 vaccine candidate and their plans to expand their pipeline of oncology and infectious disease treatments.